Researchers have struggled with the challenge of getting oral medications past the treacherous environment of the gut intact and into the bloodstream where they can be most effective. But now Sylvester Comprehensive Cancer Center and University of Miami Miller School of Medicine researchers report success in accomplishing this breakthrough using nanotechnology.
Two recent studies by Sylvester Comprehensive Cancer Center researchers are the first to suggest that immunotherapy plays a key role in treating sarcomas, namely angiosarcoma and alveolar soft-part sarcoma. The findings could change the treatment paradigm for sarcoma types that have few if any treatment options.
A researcher at Sylvester Comprehensive Cancer Center of the University of Miami Miller School of Medicine has identified a potential target for halting the unchecked cell division in medulloblastoma, the most common pediatric brain tumor. However, laboratory studies indicate that inhibiting cellular division must be done carefully during a relatively narrow window of time to avoid damage to a child’s still-developing brain.
The Mary Brickell Trailblazer Award, named after one of Miami’s founders, is given by the Greater Miami Chamber of Commerce to those at the forefront of achieving something significant, a leader in their field. On August 7 that award was presented to Director Stephen D. Nimer, M.D., on behalf of Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Sylvester Comprehensive Cancer Center, part of the University of Miami Leonard M. Miller School of Medicine, has received the prestigious NCI designation from the National Cancer Institute.
The Florida Cancer Data System, located at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, recently received three important distinctions for the quality of its cancer registry data.
A group of researchers from Sylvester Comprehensive Cancer Center, the Department of Surgery and the Department of Medicine at the University of Miami Miller School of Medicine have found that probiotics can reduce morphine tolerance when used as an adjunct therapy in germ-free mice.
Cigarette smoking is one of the major risk factors for pancreatic cancer and a focus of study for Sylvester Comprehensive Cancer Center researchers Vikas Dudeja, M.D., and Sulagna Banerjee, Ph.D. Their individual research projects, recently awarded state funding, examine different tobacco-related mechanisms that promote or drive this aggressive cancer.
David S. Kushner, M.D., clinical professor of physical medicine and rehabilitation, has been named medical director of credentialing and privileging for the University of Miami Medical Group and the University of Miami Hospital and Clinics. He will have the responsibility for ensuring that threshold qualifications are met and continuously maintained by all applicants for appointment, reappointment, or clinical privileges.
Shivank Bhatia, M.D., a member of Sylvester Comprehensive Cancer Center and associate professor of interventional radiology, has been named chair of the Department of Interventional Radiology at the University of Miami Miller School of Medicine. Dr. Bhatia has been responsible for many multidisciplinary initiatives that have moved a number of advanced clinical treatments forward.